New York Life Investment Management LLC Has $4.80 Million Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

New York Life Investment Management LLC grew its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 8.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 61,406 shares of the company's stock after purchasing an additional 4,702 shares during the quarter. New York Life Investment Management LLC's holdings in GE HealthCare Technologies were worth $4,801,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in the business. D1 Capital Partners L.P. bought a new stake in GE HealthCare Technologies in the 3rd quarter valued at $268,159,000. Van ECK Associates Corp grew its stake in shares of GE HealthCare Technologies by 107.3% in the 4th quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company's stock valued at $378,520,000 after purchasing an additional 2,506,417 shares during the period. State Street Corp raised its holdings in shares of GE HealthCare Technologies by 7.8% in the 3rd quarter. State Street Corp now owns 18,615,890 shares of the company's stock worth $1,747,101,000 after buying an additional 1,347,114 shares in the last quarter. Massachusetts Financial Services Co. MA bought a new position in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $93,713,000. Finally, Jennison Associates LLC boosted its stake in GE HealthCare Technologies by 124.5% in the 4th quarter. Jennison Associates LLC now owns 1,709,635 shares of the company's stock valued at $133,659,000 after buying an additional 948,017 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

Remove Ads

GE HealthCare Technologies Trading Down 2.2 %

NASDAQ:GEHC traded down $1.90 during trading hours on Tuesday, hitting $84.55. 2,322,096 shares of the stock were exchanged, compared to its average volume of 2,888,375. The company's 50 day moving average is $86.31 and its two-hundred day moving average is $86.14. The company has a market capitalization of $38.67 billion, a P/E ratio of 19.52, a price-to-earnings-growth ratio of 3.19 and a beta of 1.15. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.80. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

GEHC has been the subject of a number of analyst reports. Jefferies Financial Group raised GE HealthCare Technologies from a "hold" rating to a "buy" rating and lifted their price objective for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Citigroup lifted their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a report on Thursday, February 13th. Finally, Wells Fargo & Company upped their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a research note on Friday, February 14th. One research analyst has rated the stock with a sell rating, three have given a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, GE HealthCare Technologies has an average rating of "Moderate Buy" and a consensus price target of $97.67.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.